{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T20:25:23Z","timestamp":1773865523630,"version":"3.50.1"},"reference-count":86,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Tubulopathies comprise a heterogeneous and still poorly defined group of inherited and acquired disorders in which tubular transport is disproportionately impaired, resulting in chronic electrolyte and acid\u2013base disturbances with downstream complications such as nephrocalcinosis, nephrolithiasis, bone fragility and, in some entities, progressive chronic kidney disease. Over the past decade, high-cost targeted therapies have transformed outcomes for a subset of tubulopathy-related disorders with secondary tubular involvement (e.g. anti\u2013fibroblast growth factor 23 therapy in X-linked hypophosphatemia), yet comparable innovations remain largely unavailable for primary tubular transport defects and access to these therapies is uneven across healthcare systems. In this narrative review, we synthesize current evidence and expert recommendations for pragmatic, phenotype-driven interventions that support daily care and may help prevent complications. Core management still relies on non-targeted measures, including individualized nutritional counselling, optimization of hydration and solute load, and tailored electrolyte and alkali supplementation. We also discuss the rational use of widely available drugs that can be repurposed in selected tubular phenotypes, such as thiazide and thiazide-like diuretics, potassium-sparing agents, azole antifungals in calcitriol-driven hypercalcaemic states and emerging data on sodium-glucose cotransporter 2 inhibitors. Finally, we emphasize supportive care components often overlooked in \u2018drug-centred\u2019 approaches, including structured patient education, adherence support and monitoring of extra-renal manifestations. Overall, this review argues for a more resource-conscious approach to tubulopathies: one that recognizes the lack of a consensual definition, prioritizes phenotype-based care bundles, and underscores the urgent need for larger prospective studies incorporating patient-reported outcomes and robust economic endpoints, particularly the out-of-pocket burden borne by patients and families.<\/jats:p>","DOI":"10.1093\/ckj\/sfag001","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T12:40:58Z","timestamp":1767876058000},"source":"Crossref","is-referenced-by-count":0,"title":["Beyond expensive innovations: affordable and effective strategies for managing tubulopathies in adults"],"prefix":"10.1093","volume":"19","author":[{"given":"Louise","family":"Nielsen","sequence":"first","affiliation":[{"name":"Nephrology, Association ECHO , Nantes ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1473-2064","authenticated-orcid":false,"given":"Lucile","family":"Figueres","sequence":"additional","affiliation":[{"name":"Nantes Universit\u00e9, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology , UMR 1064, ITUN, Nantes ,","place":["France"]},{"name":"Reference Centers for Rare Diseases of Calcium and Phosphate (Fili\u00e8re OSCAR) and Nephrogenetic (Fili\u00e8re ORKID) , Nantes ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"2026031808522347400_bib1","first-page":"CJN.14481119","article-title":"Inherited tubulopathies of the kidney: insights from genetics","author":"Downie","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026031808522347400_bib2","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41581-019-0152-5","article-title":"Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia","volume":"15","author":"Haffner","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"2026031808522347400_bib3","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1053\/j.ajkd.2025.01.016","article-title":"Efficacy and safety of lumasiran for advanced primary hyperoxaluria type 1: 24-month follow-up of the phase 3 ILLUMINATE-C trial","volume":"86","author":"Sellier-Leclerc","year":"2025","journal-title":"Am J Kidney Dis"},{"key":"2026031808522347400_bib4","doi-asserted-by":"publisher","first-page":"sfae383","DOI":"10.1093\/ckj\/sfae383","article-title":"The efficacy and safety of RNA interference for the treatment of primary hyperoxaluria: a systematic review and meta-analysis","volume":"18","author":"Yu","year":"2025","journal-title":"Clin Kidney J"},{"key":"2026031808522347400_bib5","doi-asserted-by":"publisher","first-page":"i17","DOI":"10.1093\/ckj\/sfab245","article-title":"Primary hyperoxaluria type 1: novel therapies at a glance","volume":"15","author":"Bacchetta","year":"2022","journal-title":"Clin Kidney J"},{"key":"2026031808522347400_bib6","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1007\/s00467-025-06675-8","article-title":"Nedosiran in pediatric patients with PH1 and relatively preserved kidney function, a phase 2 study (PHYOX8)","volume":"40","author":"Sas","year":"2025","journal-title":"Pediatr Nephrol"},{"key":"2026031808522347400_bib7","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1093\/ndt\/gfaf035","article-title":"Global access to management of primary hyperoxaluria: a survey on behalf of OxalEurope, G&K working group of the ERA, and ESPN","volume":"40","author":"Deesker","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"2026031808522347400_bib8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ndt\/gfaf161","article-title":"The unmet need of electrolyte supplements","volume":"41","author":"Arjona","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"2026031808522347400_bib9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.kint.2016.09.046","article-title":"Gitelman syndrome: consensus and guidance from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"91","author":"Blanchard","year":"2017","journal-title":"Kidney Int"},{"key":"2026031808522347400_bib10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000046294","article-title":"Relationship between urinary calcium and net acid excretion as determined by dietary protein and potassium: a review","volume":"81","author":"Lemann","year":"1999","journal-title":"Nephron"},{"key":"2026031808522347400_bib11","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3945\/ajcn.2009.28614","article-title":"Effects of a low-salt diet on idiopathic hypercalciuria in calcium-oxalate stone formers: a 3-mo randomized controlled trial","volume":"91","author":"Nouvenne","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"2026031808522347400_bib12","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1097\/01.ASN.0000127864.26968.7F","article-title":"Dependence of oxalate absorption on the daily calcium intake","volume":"15","author":"von Unruh","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"2026031808522347400_bib13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1056\/NEJMoa010369","article-title":"Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria","volume":"346","author":"Borghi","year":"2002","journal-title":"N Engl J Med"},{"key":"2026031808522347400_bib14","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1016\/j.ekir.2025.09.006","article-title":"Clinical characteristics, symptoms, and long-term outcomes in Gitelman syndrome","volume":"10","author":"Wie\u00ebrs","year":"2025","journal-title":"Kidney Int Rep"},{"key":"2026031808522347400_bib15","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1681\/ASN.2019010031","article-title":"Resistance to insulin in patients with gitelman syndrome and a subtle intermediate phenotype in heterozygous carriers: a cross-sectional study","volume":"30","author":"Blanchard","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"2026031808522347400_bib16","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.3390\/nu15163510","article-title":"Industrial use of phosphate food additives: a mechanism linking ultra-processed food intake to cardiorenal disease risk?","volume":"15","author":"Calvo","year":"2023","journal-title":"Nutrients"},{"key":"2026031808522347400_bib17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41581-024-00897-z","article-title":"International expert consensus statement on the diagnosis and management of congenital nephrogenic diabetes insipidus (arginine vasopressin resistance)","volume":"21","author":"Levtchenko","year":"2025","journal-title":"Nat Rev Nephrol"},{"key":"2026031808522347400_bib18","first-page":"17","article-title":"Adult female with symptomatic AVPR2-related nephrogenic syndrome of inappropriate antidiuresis (NSIAD)","volume":"2018","author":"Hague","year":"2018","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"2026031808522347400_bib19","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1053\/j.ajkd.2011.09.026","article-title":"A family with hyponatremia and the nephrogenic syndrome of inappropriate antidiuresis","volume":"59","author":"Bockenhauer","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"2026031808522347400_bib20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2147\/IBPC.S188869","article-title":"Liddle's syndrome mechanisms, diagnosis and management","volume":"12","author":"Enslow","year":"2019","journal-title":"Integr Blood Press Control"},{"key":"2026031808522347400_bib21","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/ajh\/hpaf005","article-title":"Decoding Monogenic Hypertension: A Review of Rare Hypertension Disorders","volume":"38","author":"Gallegos","year":"2025","journal-title":"Am J Hypertens"},{"key":"2026031808522347400_bib22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1056\/NEJM200101043440101","article-title":"DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet","volume":"344","author":"Sacks","year":"2001","journal-title":"N Engl J Med"},{"key":"2026031808522347400_bib23","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.mayocp.2013.06.005","article-title":"Role of dietary salt and potassium intake in cardiovascular health and disease: a review of the evidence","volume":"88","author":"Aaron","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"2026031808522347400_bib24","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1053\/j.ajkd.2020.05.006","article-title":"KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 update","volume":"76","author":"Ikizler","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"2026031808522347400_bib25","first-page":"99","article-title":"[Evaluation of the calcium content of diet by frequential self-questionnaire]","volume":"58","author":"Fardellone","year":"1991","journal-title":"Rev Rhum Mal Osteoartic"},{"key":"2026031808522347400_bib26","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s00467-020-04873-0","article-title":"Safety, efficacy, and acceptability of ADV7103 during 24 months of treatment: an open-label study in pediatric and adult patients with distal renal tubular acidosis","volume":"36","author":"Bertholet-Thomas","year":"2021","journal-title":"Pediatr Nephrol"},{"key":"2026031808522347400_bib27","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.kint.2024.01.031","article-title":"An update on clinical presentation and responses to therapy of patients with hereditary hypophosphatemic rickets with hypercalciuria (HHRH)","volume":"105","author":"Zhu","year":"2024","journal-title":"Kidney Int"},{"key":"2026031808522347400_bib28","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1530\/EC-13-0103","article-title":"Therapeutic management of hypophosphatemic rickets from infancy to adulthood","volume":"3","author":"Linglart","year":"2014","journal-title":"Endocr Connect"},{"key":"2026031808522347400_bib29","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1681\/ASN.2007070792","article-title":"Mechanism of hypokalemia in magnesium deficiency","volume":"18","author":"Huang","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"2026031808522347400_bib30","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S0140-6736(82)90002-2","article-title":"Upper gastrointestinal lesions after potassium chloride supplements: a controlled clinical trial","volume":"320","author":"McMahon","year":"1982","journal-title":"Lancet"},{"key":"2026031808522347400_bib31","doi-asserted-by":"publisher","first-page":"260","DOI":"10.2174\/1573401313666170427162740","article-title":"Intestinal absorption and factors influencing bioavailability of magnesium - an update","volume":"13","author":"Schuchardt","year":"2017","journal-title":"Curr Nutr Food Sci"},{"key":"2026031808522347400_bib32","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12967-020-02270-7","article-title":"Use of thiazide diuretics for the prevention of recurrent kidney calculi: a systematic review and meta-analysis","volume":"18","author":"Li","year":"2020","journal-title":"J Transl Med"},{"key":"2026031808522347400_bib33","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.juro.2014.05.006","article-title":"Medical management of kidney stones: AUA guideline","volume":"192","author":"Pearle","year":"2014","journal-title":"J Urol"},{"key":"2026031808522347400_bib34","doi-asserted-by":"publisher","first-page":"535","DOI":"10.7326\/0003-4819-158-7-201304020-00005","article-title":"Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline","volume":"158","author":"Fink","year":"2013","journal-title":"Ann Intern Med"},{"key":"2026031808522347400_bib35","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1056\/NEJMoa2209275","article-title":"Hydrochlorothiazide and prevention of kidney-stone recurrence","volume":"388","author":"Dhayat","year":"2023","journal-title":"N Engl J Med"},{"key":"2026031808522347400_bib36","doi-asserted-by":"publisher","first-page":"e2428953","DOI":"10.1001\/jamanetworkopen.2024.28953","article-title":"Thiazide dose, urine calcium, and symptomatic kidney stone events","volume":"7","author":"Hsi","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026031808522347400_bib37","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1097\/01.ASN.0000036869.82685.F6","article-title":"Responsiveness of hypercalciuria to thiazide in Dent\u2019s disease","volume":"13","author":"Raja","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"2026031808522347400_bib38","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/ndt\/gfz099","article-title":"Understanding and managing hypercalciuria in adults with nephrolithiasis: keys for nephrologists","volume":"35","author":"Figueres","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"2026031808522347400_bib39","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s40264-016-0487-9","article-title":"Melanoma and non-melanoma skin cancer associated with angiotensin-converting-enzyme inhibitors, angiotensin-receptor blockers and thiazides: a matched cohort study","volume":"40","author":"Nardone","year":"2017","journal-title":"Drug Saf"},{"key":"2026031808522347400_bib40","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.3945\/ajcn.115.120873","article-title":"Vitamin D deficiency in Europe: pandemic?","volume":"103","author":"Cashman","year":"2016","journal-title":"Am J Clin Nutr"},{"key":"2026031808522347400_bib41","doi-asserted-by":"publisher","first-page":"1070808","DOI":"10.3389\/fnut.2023.1070808","article-title":"Global and regional prevalence of vitamin D deficiency in population-based studies from 2000 to 2022: a pooled analysis of 7.9 million participants","volume":"10","author":"Cui","year":"2023","journal-title":"Front Nutr"},{"key":"2026031808522347400_bib42","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/bonekey.2013.233","article-title":"Vitamin D: direct effects of vitamin D metabolites on bone: lessons from genetically modified mice","volume":"3","author":"Eisman","year":"2014","journal-title":"Bonekey Rep"},{"key":"2026031808522347400_bib43","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3945\/ajcn.116.134981","article-title":"Hypercalcemia, hypercalciuria, and kidney stones in long-term studies of vitamin D supplementation: a systematic review and meta-analysis","volume":"104","author":"Malihi","year":"2016","journal-title":"Am J Clin Nutr"},{"key":"2026031808522347400_bib44","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1210\/er.2016-1070","article-title":"Vitamin D-mediated hypercalcemia: mechanisms, diagnosis, and treatment","volume":"37","author":"Tebben","year":"2016","journal-title":"Endocr Rev"},{"key":"2026031808522347400_bib45","first-page":"270","article-title":"Ketoconazole decreases the serum ionized calcium and 1,25-dihydroxyvitamin D levels in tuberculosis-associated hypercalcemia","volume":"147","author":"Saggese","year":"1993","journal-title":"Am J Dis Child 1960"},{"key":"2026031808522347400_bib46","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S0272-6386(12)80613-5","article-title":"Treatment of sarcoidosis-associated hypercalcemia with ketoconazole","volume":"18","author":"Bia","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"2026031808522347400_bib47","doi-asserted-by":"publisher","first-page":"E423","DOI":"10.1210\/jc.2011-1935","article-title":"Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy","volume":"97","author":"Tebben","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2026031808522347400_bib48","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000485243","article-title":"A case report of compound heterozygous CYP24A1 mutations leading to nephrolithiasis successfully treated with ketoconazole","volume":"7","author":"Davidson Peiris","year":"2017","journal-title":"Case Rep Nephrol Dial"},{"key":"2026031808522347400_bib49","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1093\/ckj\/sfv028","article-title":"Successful treatment of hypercalcaemia associated with a CYP24A1 mutation with fluconazole","volume":"8","author":"Sayers","year":"2015","journal-title":"Clin Kidney J"},{"key":"2026031808522347400_bib50","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1186\/s13063-022-06302-z","article-title":"Fluconazole in hypercalciuric patients with increased 1,25(OH)2D levels: the prospective, randomized, placebo-controlled, double-blind FLUCOLITH trial","volume":"23","author":"Bertholet-Thomas","year":"2022","journal-title":"Trials"},{"key":"2026031808522347400_bib51","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1007\/s00125-021-05424-4","article-title":"Sodium-glucose cotransporter 2 inhibitors and risk of nephrolithiasis","volume":"64","author":"Kristensen","year":"2021","journal-title":"Diabetologia"},{"key":"2026031808522347400_bib52","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41591-024-03330-x","article-title":"Empagliflozin in nondiabetic individuals with calcium and uric acid kidney stones: a randomized phase 2 trial","volume":"31","author":"Anderegg","year":"2025","journal-title":"Nat Med"},{"key":"2026031808522347400_bib53","first-page":"e20230146","article-title":"Sodium-glucose cotranspor ter 2 (SGLT2) inhibitors in nephrolithiasis: should we \u2018gliflozin\u2019 patients with kidney stone disease?","volume":"46","author":"Carvalho","year":"2024","journal-title":"J Bras Nefrol"},{"key":"2026031808522347400_bib54","doi-asserted-by":"publisher","first-page":"e3003","DOI":"10.1210\/clinem\/dgac154","article-title":"Empagliflozin and decreased risk of nephrolithiasis: a potential new role for SGLT2 inhibition?","volume":"107","author":"Balasubramanian","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2026031808522347400_bib55","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.kint.2020.10.035","article-title":"Diagnosis and management of Bartter syndrome: executive summary of the consensus and recommendations from the European Rare Kidney Disease Reference Network Working Group for Tubular Disorders","volume":"99","author":"Konrad","year":"2021","journal-title":"Kidney Int"},{"key":"2026031808522347400_bib56","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1681\/ASN.V971264","article-title":"Dipyridamole decreases renal phosphate leak and augments serum phosphorus in patients with low renal phosphate threshold","volume":"9","author":"Pri\u00e9","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"2026031808522347400_bib57","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1053\/j.ajkd.2018.12.026","article-title":"Fluconazole as a new therapeutic tool to manage patients with NPTIIc (SLC34A3) mutation: a case report","volume":"73","author":"Bertholet-Thomas","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"2026031808522347400_bib58","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000168804","article-title":"Treatment of idiopathic renal magnesium wasting with amiloride","volume":"15","author":"Bundy","year":"1995","journal-title":"Am J Nephrol"},{"key":"2026031808522347400_bib59","first-page":"274","article-title":"Magnesium- and potassium-sparing effects of amiloride. Review and recent findings","volume":"3","author":"Ryan","year":"1984","journal-title":"Magnesium"},{"key":"2026031808522347400_bib60","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.1016\/j.ekir.2025.07.035","article-title":"Novel RRAGD variants in autosomal dominant kidney hypomagnesemia and therapeutic perspectives","volume":"10","author":"Adella","year":"2025","journal-title":"Kidney Int Rep"},{"key":"2026031808522347400_bib61","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1053\/j.ajkd.2023.11.006","article-title":"Sodium\/glucose cotransporter 2 inhibitors and magnesium homeostasis: a review","volume":"83","author":"Shah","year":"2024","journal-title":"Am J Kidney Dis"},{"key":"2026031808522347400_bib62","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1136\/adc.80.6.548","article-title":"Treatment of nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride","volume":"80","author":"Kirchlechner","year":"1999","journal-title":"Arch Dis Child"},{"key":"2026031808522347400_bib63","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/ki.2015.181","article-title":"Mutation in the V2 vasopressin receptor gene, AVPR2, causes nephrogenic syndrome of inappropriate diuresis","volume":"88","author":"Erd\u00e9lyi","year":"2015","journal-title":"Kidney Int"},{"key":"2026031808522347400_bib64","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1681\/ASN.2019090944","article-title":"A randomized Trial of empagliflozin to increase plasma sodium levels in patients with the syndrome of inappropriate antidiuresis","volume":"31","author":"Refardt","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"2026031808522347400_bib65","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/jimd.12752","article-title":"Repurposing SGLT2 inhibitors: treatment of renal proximal tubulopathy in Fanconi-Bickel syndrome with empagliflozin","volume":"47","author":"Overduin","year":"2024","journal-title":"J Inherit Metab Dis"},{"key":"2026031808522347400_bib66","first-page":"CD012026","article-title":"Interventions for improving health literacy in people with chronic kidney disease","volume":"12","author":"Campbell","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"2026031808522347400_bib67","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/jorc.12462","article-title":"Effectiveness of teach-back for chronic kidney disease patient education: a systematic review","volume":"50","author":"Jagodage","year":"2024","journal-title":"J Renal Care"},{"key":"2026031808522347400_bib68","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1053\/j.ajkd.2014.06.037","article-title":"Kidney function and influence of sunlight exposure in patients with impaired 24-hydroxylation of vitamin D due to CYP24A1 mutations","volume":"65","author":"Figueres","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"2026031808522347400_bib69","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1093\/ndt\/gfab171","article-title":"Distal renal tubular acidosis: ERKNet\/ESPN clinical practice points","volume":"36","author":"Trepiccione","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"2026031808522347400_bib70","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/0022034513507066","article-title":"Ion channels, channelopathies, and tooth formation","volume":"93","author":"Duan","year":"2014","journal-title":"J Dent Res"},{"key":"2026031808522347400_bib71","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1177\/0022034518824571","article-title":"WDR72 mutations associated with amelogenesis imperfecta and acidosis","volume":"98","author":"Zhang","year":"2019","journal-title":"J Dent Res"},{"key":"2026031808522347400_bib72","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1093\/ckj\/sfab279","article-title":"Genetic evaluation of paediatric nephrocalcinosis: phenotype-driven genetic panels reveal a rare diagnosis","volume":"15","author":"Patterson","year":"2022","journal-title":"Clin Kidney J"},{"key":"2026031808522347400_bib73","doi-asserted-by":"publisher","first-page":"p62","DOI":"10.1159\/000322828","article-title":"Amelogenesis imperfecta and nephrocalcinosis syndrome: a case report and review of the literature","volume":"118","author":"Martelli-J\u00fanior","year":"2011","journal-title":"Nephron Physiol"},{"key":"2026031808522347400_bib74","doi-asserted-by":"publisher","first-page":"5701","DOI":"10.3390\/ijms22115701","article-title":"The complexities of organ crosstalk in phosphate homeostasis: time to put phosphate sensing back in the limelight","volume":"22","author":"Figueres","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026031808522347400_bib75","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1210\/clinem\/dgae398","article-title":"Improved oral health in adults with X-linked hypophosphatemia treated with burosumab","volume":"110","author":"Herv\u00e9","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"2026031808522347400_bib76","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3389\/fphys.2017.00326","article-title":"Claudin loss-of-function disrupts tight junctions and impairs amelogenesis","volume":"8","author":"Bardet","year":"2017","journal-title":"Front Physiol"},{"key":"2026031808522347400_bib77","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1136\/jmedgenet-2016-103956","article-title":"Amelogenesis imperfecta in familial hypomagnesaemia and hypercalciuria with nephrocalcinosis caused by CLDN19 gene mutations","volume":"54","author":"Yamaguti","year":"2017","journal-title":"J Med Genet"},{"key":"2026031808522347400_bib78","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/jbmr.2726","article-title":"Claudin-16 deficiency impairs tight junction function in ameloblasts, leading to abnormal enamel formation","volume":"31","author":"Bardet","year":"2016","journal-title":"J Bone Miner Res"},{"key":"2026031808522347400_bib79","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1046\/j.1523-1755.2003.00815.x","article-title":"Effect of vitamin C supplements on urinary oxalate and pH in calcium stone-forming patients","volume":"63","author":"Baxmann","year":"2003","journal-title":"Kidney Int"},{"key":"2026031808522347400_bib80","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.euros.2020.07.006","article-title":"What stone-formers should know about vitamin C and D supplementation in the COVID-19 era","volume":"21","author":"Khusid","year":"2020","journal-title":"Eur Urol Open Sci"},{"key":"2026031808522347400_bib81","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1053\/j.ajkd.2015.09.005","article-title":"Total, dietary, and supplemental vitamin C intake and risk of incident kidney stones","volume":"67","author":"Ferraro","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"2026031808522347400_bib82","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1111\/bcp.13573","article-title":"A review of the growing risk of vitamin D toxicity from inappropriate practice","volume":"84","author":"Taylor","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"2026031808522347400_bib83","doi-asserted-by":"crossref","first-page":"816965","DOI":"10.3389\/fped.2022.816965","article-title":"Case report: severe hypercalcemia following vitamin D intoxication in an infant, the underestimated danger of dietary supplements","volume":"10","author":"G\u00e9rard","year":"2022","journal-title":"Front Pediatr"},{"key":"2026031808522347400_bib84","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1056\/NEJMc2400528","article-title":"Kidney injury and hair-straightening products containing glyoxylic acid","volume":"390","author":"Robert","year":"2024","journal-title":"N Engl J Med"},{"key":"2026031808522347400_bib85","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1056\/NEJMoa1714641","article-title":"Burosumab therapy in children with X-linked hypophosphatemia","volume":"378","author":"Carpenter","year":"2018","journal-title":"N Engl J Med"},{"key":"2026031808522347400_bib86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4061\/2011\/864580","article-title":"Primary hyperoxaluria","volume":"2011","author":"Harambat","year":"2011","journal-title":"Int J Nephrol"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfag001\/66326022\/sfag001.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/3\/sfag001\/66326022\/sfag001.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/3\/sfag001\/66326022\/sfag001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:56:19Z","timestamp":1773838579000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfag001\/8418242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":86,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfag001","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2026,1,9]]},"article-number":"sfag001"}}